EssilorLuxottica [EL] vs Amplitude Surgical [AMPLI] Detailed Stock Comparison

EssilorLuxottica

Euronext
Loading...

Amplitude Surgical

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: EssilorLuxottica wins in 11 metrics, Amplitude Surgical wins in 6 metrics, with 0 ties. EssilorLuxottica appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricEssilorLuxotticaAmplitude SurgicalBetter
P/E Ratio (TTM)53.38312.50EssilorLuxottica
Price-to-Book Ratio3.353.17Amplitude Surgical
Debt-to-Equity Ratio36.58126.32EssilorLuxottica
PEG Ratio35.84N/AN/A
EV/EBITDA24.6416.04Amplitude Surgical
Profit Margin (TTM)8.74%1.00%EssilorLuxottica
Operating Margin (TTM)14.25%11.52%EssilorLuxottica
EBITDA Margin (TTM)14.25%11.52%EssilorLuxottica
Return on Equity6.44%1.15%EssilorLuxottica
Return on Assets (TTM)3.58%3.10%EssilorLuxottica
Free Cash Flow (TTM)$3.35B$-14.89MEssilorLuxottica
Dividend Yield1.64%N/AN/A
1-Year Return28.58%94.97%Amplitude Surgical
Price-to-Sales Ratio (TTM)4.652.76Amplitude Surgical
Enterprise Value$138.62B$399.98MEssilorLuxottica
EV/Revenue Ratio5.093.69Amplitude Surgical
Revenue per Share (TTM)$60$2EssilorLuxottica
Earnings per Share (Diluted)$5.15$0.02EssilorLuxottica
Beta (Stock Volatility)0.750.13Amplitude Surgical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

EssilorLuxottica vs Amplitude Surgical Stock Performance Analysis

Loading Price Chart...

EssilorLuxottica
Amplitude Surgical
EssilorLuxottica Stock Overview | Amplitude Surgical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
EssilorLuxottica-0.18%1.40%1.93%14.00%1.44%17.16%
Amplitude Surgical-0.80%0.00%0.00%0.81%2.48%93.75%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
EssilorLuxottica28.58%95.51%131.56%147.65%298.72%298.72%
Amplitude Surgical94.97%115.28%191.08%35.08%26.53%26.53%

News Based Sentiment: EssilorLuxottica vs Amplitude Surgical

EssilorLuxottica

News based Sentiment: POSITIVE

September brought a wave of positive developments for EssilorLuxottica, including a Moody's rating upgrade, bullish analyst revisions, and continued success in its AI glasses segment. While some analyst caution exists, the overall narrative is one of strengthening performance and future growth potential.

View EssilorLuxottica News Sentiment Analysis

Amplitude Surgical

News based Sentiment: POSITIVE

Zydus Lifesciences is rapidly executing its plan to acquire and integrate Amplitude Surgical, demonstrating a clear strategy for growth in the European orthopedic market. The strong financial performance of Amplitude Surgical and the market's confidence in the tender offer suggest a positive outlook for the acquisition's success.

View Amplitude Surgical News Sentiment Analysis

Performance & Financial Health Analysis: EssilorLuxottica vs Amplitude Surgical

MetricELAMPLI
Market Information
Market Cap i€126.54B€299.85M
Market Cap CategoryLarge capMid cap
10 Day Avg. Volume i440,4137,973
90 Day Avg. Volume i397,22913,311
Last Close€274.40€6.20
52 Week Range€202.10 - €298.00€2.96 - €6.25
% from 52W High-7.92%-0.80%
All-Time High€298.00 (Feb 10, 2025)€6.25 (May 30, 2025)
% from All-Time High-7.92%-0.80%
Growth Metrics
Quarterly Revenue Growth0.06%0.05%
Quarterly Earnings Growth0.02%N/A
Financial Health
Profit Margin (TTM) i0.09%0.01%
Operating Margin (TTM) i0.14%0.12%
Return on Equity (TTM) i0.06%0.01%
Debt to Equity (MRQ) i36.58126.32
Cash & Liquidity
Book Value per Share (MRQ)€82.02€1.97
Cash per Share (MRQ)€6.04€0.41
Operating Cash Flow (TTM) i€4.91B€5.93M
Levered Free Cash Flow (TTM) i€3.07B€-11,550,125
Dividends
Last 12-Month Dividend Yield i1.64%N/A
Last 12-Month Dividend i€3.95N/A

Valuation & Enterprise Metrics Analysis: EssilorLuxottica vs Amplitude Surgical

MetricELAMPLI
Price Ratios
P/E Ratio (TTM) i53.38312.50
Forward P/E i35.84N/A
PEG Ratio i35.84N/A
Price to Sales (TTM) i4.652.76
Price to Book (MRQ) i3.353.17
Market Capitalization
Market Capitalization i€126.54B€299.85M
Enterprise Value i€138.62B€399.98M
Enterprise Value Metrics
Enterprise to Revenue i5.093.69
Enterprise to EBITDA i24.6416.04
Risk & Other Metrics
Beta i0.750.13
Book Value per Share (MRQ) i€82.02€1.97

Financial Statements Comparison: EssilorLuxottica vs Amplitude Surgical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ELAMPLI
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ELAMPLI
Cash & Equivalents i€2.79B€19.78M
Total Current Assets i€11.03B€91.32M
Total Current Liabilities i€11.39B€47.76M
Long-Term Debt i€9.37B€102.78M
Total Shareholders Equity i€38.41B€94.70M
Retained Earnings i€1.39B€-616,000
Property, Plant & Equipment i€2.49B€68.83M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ELAMPLI
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricELAMPLI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i440,4137,973
Average Daily Volume (90 Day) i397,22913,311
Shares Outstanding i456.71M47.97M
Float Shares i293.63M4.53M
% Held by Insiders i0.37%0.91%
% Held by Institutions i0.29%0.00%

Dividend Analysis & Yield Comparison: EssilorLuxottica vs Amplitude Surgical

MetricELAMPLI
Last 12-Month Dividend i€3.95N/A
Last 12-Month Dividend Yield i1.64%N/A
3-Year Avg Annual Dividend i€3.71N/A
3-Year Avg Dividend Yield i1.79%N/A
3-Year Total Dividends i€11.13N/A
Ex-Dividend DateMay 07, 2025N/A